@coolkiat when you look at Fate Therapeutics in the US as a comparison it would seem our market will wake up at some point.
With Fate's current MCap US $10 billion one could argue we are on the cheap side
Not to say we should be worth those multiples in the Aus market but at $100 million MC we do look undervalued
https://fatetherapeutics.com/science/ipsc-product-platform/
CYP 2021 - The year ahead, page-10
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
-0.005(2.08%) |
Mkt cap ! $42.45M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 23.5¢ | $9.79K | 41.04K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3942 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 35000 | 1 |
View Market Depth
| Last trade - 14.18pm 14/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |